ArrowMark Colorado Holdings’s Dianthus Therapeutics DNTH Stock Holding History
Bought
Maintained
Sold
Other funds holding DNTH
ArrowMark Colorado Holdings's DNTH Position: Q3 2026 in Review
ArrowMark Colorado Holdings held its Dianthus Therapeutics (DNTH) position steady in Q3 2026 at 20,788 shares worth $1.83M. The position accounts for 0.09% of the portfolio, ranked #227.
ArrowMark Colorado Holdings first reported a position in DNTH in Q3 2023 and has held it in 13 quarters since. The position peaked at $2.03M in Q2 2026. 275 funds tracked by Wall St. Rank hold DNTH as of Q3 2026.
- ArrowMark Colorado Holdings held 20,788 shares of Dianthus Therapeutics worth $1.83M as of Q3 2026.
- ArrowMark Colorado Holdings left its Dianthus Therapeutics share count unchanged in Q3 2026.
- Dianthus Therapeutics made up 0.09% of ArrowMark Colorado Holdings's portfolio in Q3 2026, its #227 holding.
- ArrowMark Colorado Holdings first reported a position in Dianthus Therapeutics in Q3 2023 and has held it in 13 quarters since.
- ArrowMark Colorado Holdings's Dianthus Therapeutics position peaked at $2.03M in Q2 2026.
- 275 funds tracked by Wall St. Rank held Dianthus Therapeutics as of Q3 2026.
Based on ArrowMark Colorado Holdings's 13F filing for Q3 2026, filed 16 Nov 2026.